Oncocross Co., Ltd. (KOSDAQ:382150)

Oncocross Revenue

Oncocross had revenue of 167.27M KRW in the quarter ending March 31, 2026, with 167.31% growth. This brings the company's revenue in the last twelve months to 475.15M, down -55.77% year-over-year. In the year 2025, Oncocross had annual revenue of 370.46M, down -65.45%.

• Revenue (ttm): 475.15M
• Revenue Growth: -55.77%
• P/S Ratio: 120.64
• Revenue / Employee: n/a
• Employees: n/a
• Market Cap: 57.32B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	370.46M	-701.74M	-65.45%
Dec 31, 2024	1.07B	980.68M	1,071.49%
Dec 31, 2023	91.52M	-58.72M	-39.08%
Dec 31, 2022	150.25M	50.25M	50.25%
Dec 31, 2021	100.00M	10.00M	11.11%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jun 9, 2026

Data Sources Report a data error